🇮🇹 Italy Country × Condition
lung cancer Clinical Trials in Italy
Active clinical trials for lung cancer with research sites in Italy. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 6 // Recruiting: 6 // Updated: Daily
Total Trials
6
Recruiting Now
6
Country
🇮🇹 Italy
Active Trials in Italy (6)
NCT06496386
Recruiting
Robotic Assisted Major Lung Resection in Elderly Patients
Enrollment
386 pts
Country
🇮🇹 Italy
Scientific Institute San Raffaele
View Trial → NCT06451029
Recruiting
Prevention of Smoking Related Diseases
Enrollment
189 pts
Country
🇮🇹 Italy
Scientific Institute San Raffaele
View Trial → NCT05550961
Recruiting
APOLLO 11, Consortium of Italian Centers Involved in Treatment of Patients With Lung Cancer Treated With Innovative Therapies: Real World Data and Translational Reaserch
Enrollment
1,200 pts
Country
🇮🇹 Italy
Fondazione IRCCS Istituto Nazionale...
View Trial → NCT04075305
Recruiting
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Enrollment
8,000 pts
Country
🇮🇹 Italy
UMC Utrecht
View Trial → NCT06470607
Recruiting
The Lymphocytic Infiltrate of Lung Tumors.
Enrollment
70 pts
Country
🇮🇹 Italy
Scientific Institute San Raffaele
View Trial → NCT05681962
Recruiting
Practice of Oxygenation and Respiratory Support During Fiberoptic Bronchoscopy
Enrollment
10,000 pts
Country
🇮🇹 Italy
University Magna Graecia
View Trial → Frequently Asked Questions
How many lung cancer clinical trials are active in Italy?
There are currently 6 active clinical trials for lung cancer with sites in Italy, of which 6 are actively recruiting patients.
How can I join a lung cancer clinical trial in Italy?
To join a lung cancer clinical trial in Italy, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Italy directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are lung cancer trials in Italy?
Active lung cancer trials in Italy span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology